Industry-Led Consortia to Advance Therapeutic Targets and Biomarkers for ALS and FTD

Sponsor: Target ALS Foundation and the Association for Frontotemporal Degeneration

Due Date: Letters of intent for ILCs by December 2, 2019

Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Basic Science (R03 Clinical Trials Not Allowed) (PAS-19-392)

Sponsor: National Institute on Aging

Award: NIH intends to fund an estimated 12 awards for this FOA and its companions, corresponding to a total of $1.8 million, for fiscal year 2020. Future year amounts will depend on annual appropriations.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. The first standard due date for this FOA is February 16, 2020.

Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed

Sponsor: National Institute on Aging

Award: NIH intends to fund an estimated 12 awards for this FOA and its companions, corresponding to a total of $1.8 million, for fiscal year 2020. Future year amounts will depend on annual appropriations.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. The first standard due date for this FOA is February 16, 2020.

Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed) (PAS-19-393)

Sponsor: National Institute on Aging

Award: NIH intends to fund an estimated 12 awards for this FOA and its companions, corresponding to a total of $1.8 million, for fiscal year 2020. Future year amounts will depend on annual appropriations.

Due Date: Standard dates apply, by 5 p.m. The first standard due date for this FOA is February 16, 2020.

Collaborative Pairs Pilot Project Awards

Sponsor: Chan Zuckerberg Initiative Neurodegeneration Challenge Network

Award: $150,000 in total costs per pair, and successful pilots will be eligible to apply for additional four-year project development grants

Due Date: January 14, 2020

AD-RCMAR Research Scientist Enrichment Program

Sponsor: Michigan Center for Contextual Factors in Alzheimer's Disease

Award: Up to $30,000

Due Date: January 10, 2020

Low Cost Detection of Cognitive Decline in Clinical Settings (R61/R33 Clinical Trial Required) (RFA-AG-20-050)

Sponsor: National Institute on Aging

Award: NIA intends to commit $4 million in FY 2020 to fund three or four awards..

Due Date: January 30, 2020.

Low Cost Detection of Cognitive Decline in Clinical Settings (R01 Clinical Trial Required) (RFA-AG-20-051)

Sponsor: National Institute on Aging

Award: NIA intends to commit $4 million in FY 2020 to fund two or three awards.

Due Date: January 30, 2020.

Ken Griffin Alpha-synuclein Imaging Competition

Sponsor: The Michael J. Fox Foundation for Parkinson's Research

Award: Up to $8.5 million

Due Date: January 17, 2020

NIH Blueprint for Neuroscience Research Education Program on Translational Devices (R25 Clinical Trial Not Allowed) (RFA-NS-20-003)

Sponsor: National Institutes of Health

Award: The following NIH components intend to commit approximately $250,000 to fund one award in FY 2020:

Due Date: December 16, 2019.

Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required) (PAR-19-384)

Sponsor: National Institutes of Health

Due Date: March 17, 2020; March 17, 2021.

Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed) (PAR-19-373)

Sponsor: National Institutes of Health

Due Date: March 17, 2020; March 17, 2021.

Single-Cell Analysis of Inflammation

Sponsor: Chan Zuckerberg Initiative

Award: Applicants can request up to $175,000 in total costs per lab.

Due Date: November 19, 2019, by 5 p.m.

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) (PAR-19-376)

Sponsor: National Institutes of Health

Due Date: November 19, 2019; September 24, 2020.

Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) (PAR-19-374)

Sponsor: National Institute on Aging

Due Date: Standard dates apply. The first standard due date for this FOA is January 25, 2020. All applicants are due by 5 p.m. local time of applicant organization.